Literature DB >> 16391471

Hemoperfusion with an immobilized polymyxin B column reduces the blood level of neutrophil elastase.

Hidehiko Kushi1, Takahiro Miki, Jun Nakahara, Kazuhiko Okamoto, Takeshi Saito, Katsuhisa Tanjoh.   

Abstract

BACKGROUND: We investigated whether direct hemoperfusion with an immobilized polymyxin B column (DHP with PMX) could reduce the blood level of neutrophil elastase.
METHODS: 20 sepsis patients were enrolled in the study. DHP with PMX was performed twice within a 24-hour period. Neutrophil elastase was measured 7 times.
RESULTS: Neutrophil elastase was 468 +/- 75.1 microg/l, while it was 1,531 +/- 201.7 microg/l immediately after the first session, declined to 351 +/- 73.9 microg/l before the second session of DHP with PMX, and increased again to 599.3 +/- 112.7 microg/l immediately after the second session, 328 +/- 73.7 microg/l at 24 h, 264 +/- 39.3 microg/l at 48 h, and 230 +/- 36.1 microg/l at 72 h after DHP with PMX. The levels from 48 h onwards were significantly lower compared with that before treatment.
CONCLUSION: DHP with PMX has an overall effect that reduces circulating neutrophil elastase levels. (c) 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391471     DOI: 10.1159/000090593

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  8 in total

1.  Early recovery in hemodynamics after direct hemoperfusion with polymyxin B-immobilized fibers may predict mortality rate in patients with septic shock.

Authors:  Atsuko Kobayashi; Yasushi Iwasaki; Yuichi Kimura; Yoshiaki Kawagoe; Yoshihito Ujike
Journal:  J Anesth       Date:  2010-07-17       Impact factor: 2.078

2.  Intraoperative direct hemoperfusion with a polymyxin-B immobilized fiber column for treatment of infective endocarditis.

Authors:  Toshinori Totsugawa; Masahiko Kuinose; Hidenori Yoshitaka; Yoshimasa Tsushima; Atsuhisa Ishida; Genta Chikazawa; Keijiro Katayama; Arudo Hiraoka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-02-10

3.  Treatment of acute exacerbation of idiopathic pulmonary fibrosis with direct hemoperfusion using a polymyxin B-immobilized fiber column improves survival.

Authors:  Noriyuki Enomoto; Masashi Mikamo; Yoshiyuki Oyama; Masato Kono; Dai Hashimoto; Tomoyuki Fujisawa; Naoki Inui; Yutaro Nakamura; Hideo Yasuda; Akihiko Kato; Soichiro Mimuro; Matsuyuki Doi; Shigehito Sato; Takafumi Suda
Journal:  BMC Pulm Med       Date:  2015-02-22       Impact factor: 3.317

4.  Septic shock from descending necrotizing mediastinitis - combined treatment with IgM-enriched immunoglobulin preparation and direct polymyxin B hemoperfusion: a case report.

Authors:  Vincenzo Pota; Maria Beatrice Passavanti; Pasquale Sansone; Maria Caterina Pace; Filomena Peluso; Alfonso Fiorelli; Caterina Aurilio
Journal:  J Med Case Rep       Date:  2018-03-03

5.  A systematic review of the efficacy of direct hemoperfusion with a polymyxin B-immobilized fibre column to treat rapidly progressive interstitial pneumonia.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  SAGE Open Med       Date:  2019-07-08

Review 6.  Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.

Authors:  Dinna N Cruz; Mark A Perazella; Rinaldo Bellomo; Massimo de Cal; Natalia Polanco; Valentina Corradi; Paolo Lentini; Federico Nalesso; Takuya Ueno; V Marco Ranieri; Claudio Ronco
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

7.  Effect of hemoperfusion using polymyxin B-immobilized fibers on acute lung injury in a rat sepsis model.

Authors:  Toshiaki Iba; Isao Nagaoka; Atsushi Yamada; Masataka Nagayama; Takahiro Miki
Journal:  Int J Med Sci       Date:  2014-01-17       Impact factor: 3.738

Review 8.  Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge.

Authors:  Elisabeth Esteban; Ricard Ferrer; Laia Alsina; Antonio Artigas
Journal:  Mediators Inflamm       Date:  2013-10-22       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.